Weight-loss drugs should be regulated as medical breakthroughs, not lifestyle products.

Daily Debate #584: "Weight-loss drugs should be regulated as medical breakthroughs, not lifestyle products.". You are arguing FOR the motion. Your opponent: Hannah Arendt.

GLP1's should not be treated like lifestyle products. They are serious medications that need prescriptions and have substantial side effects.

You're confusing regulation with reality. GLP-1s *already require prescriptions* and carry black box warnings. Calling them "breakthroughs" doesn't change that—it just means they work. Why rebrand something already tightly controlled?